Oxfam calls for an end to billionaire ‘bonanza,’ say millions are falling into extreme poverty

Oxfam calls for an end to billionaire ‘bonanza,’ say millions are falling into extreme poverty


Olga Shumytskaya | Moment | Getty Images

A new billionaire emerged every 30 hours during the Covid-19 pandemic, and nearly a million could fall into extreme poverty at around the same rate in 2022. Those are the sobering statistics recently released by Oxfam.

There were 573 more billionaires in the world by March 2022 than in 2020, when the pandemic began, the global charity said in a brief that was published on Monday, the first day of the World Economic Forum summit in Davos, Switzerland. That equates to one new billionaire every 30 hours, Oxfam said.

On top of that, it estimated that 263 million people could be pushed into extreme levels of poverty in 2022 because of the pandemic, growing global inequality and rising food prices that have been exacerbated by the war in Ukraine. That’s the equivalent of nearly a million people every 33 hours, Oxfam said.

The organization pointed out that billionaires were collectively worth $12.7 trillion as of March. In 2021, billionaire wealth represented the equivalent of nearly 14% of global gross domestic product.

Gabriela Bucher, executive director of Oxfam International, said that billionaires were arriving at the Davos summit to “celebrate an incredible surge in their fortunes.”

“The pandemic and now the steep increases in food and energy prices have, simply put, been a bonanza for them,” she said.

“Meanwhile, decades of progress on extreme poverty are now in reverse and millions of people are facing impossible rises in the cost of simply staying alive,” Bucher added.

Pandemic windfalls

Honing in on soaring wealth in specific business sectors, Oxfam said the fortunes of food and energy billionaires rose by $453 billion in the last two years, equating to $1 billion every two days.

For instance, food giant Cargill was reported to be one of four companies that control more than 70% of global agricultural market, Oxfam said. The corporation, owned by the Cargill family, generated a net income of nearly $5 billion last year — the biggest profit in its history. There are now 12 billionaires in the Cargill family alone, it said, up from eight prior to the pandemic.

Meanwhile, Oxfam said the pandemic created 40 new billionaires in the pharmaceuticals sector. The billionaires are those who profited from their companies’ monopolies over vaccines, treatments, tests and personal protective equipment.

In order to prevent even starker wealth inequality, and to support people with rising food and energy costs, Oxfam recommended that governments impose one-off solidarity taxes on the pandemic windfalls of billionaires.

Ending ‘crisis profiteering’?





Source

The  million Trump Card faces legal challenges, limited market
Business

The $5 million Trump Card faces legal challenges, limited market

U.S. President Donald Trump holds “The Trump Card” as he speaks with journalists onboard Air Force One en route to Miami, Florida, U.S., April 3, 2025. Kent Nishimura | Reuters A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to […]

Read More
Nike will report earnings after the bell. Here’s what Wall Street expects
Business

Nike will report earnings after the bell. Here’s what Wall Street expects

A shopper walks past a Nike store, as global markets brace for a hit to trade and growth caused by U.S. President Donald Trump’s decision to impose import tariffs on dozens of countries, in the King of Prussia Mall in King of Prussia, Pennsylvania, U.S., April 3, 2025.  Rachel Wisniewski | Reuters Nike is expected […]

Read More
RFK Jr.’s CDC vaccine panel backs Merck RSV shot for infants
Business

RFK Jr.’s CDC vaccine panel backs Merck RSV shot for infants

Nikos Pekiaridis | Nurphoto | Getty Images Robert F. Kennedy Jr.’s revamped government panel of outside vaccine advisors on Thursday recommended the use of Merck‘s shot to protect infants from respiratory syncytial virus, a temporary reprieve for public health officials and companies concerned about the Health and Human Services secretary’s immunization policy. The group, called […]

Read More